Search
for
Sort by
Research 31–60 of 354
- Adverse Cutaneous Reactions to Mood Stabilizers
- Baseline methotrexate does not impact the incidence of infliximab infusion reactions: Results from a Canadian real-world treatment registry
- Psychodermatology
- Novel drugs of United States Food and Drug Administration approved in 2024
- Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box–Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route
- Hair Changes due to Drugs
- Men??s Health
- Psychocutaneous disease
- Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress
- The Hair Growth-Promoting Effect of<i>Rumex japonicus</i>Houtt. Extract
- Treatment of Delusional Infestation with Olanzapine
- Reporting on Adverse Clinical Events
- Drug Reactions Affecting Hair: Diagnosis
- Understanding Polycystic Ovary Syndrome
- Vitamin D Adequacy Conditions the Prolactin-Suppressive Effect of Metformin in Men Receiving Prolactin-Elevating Medications
- PD29-07 DRUGS ASSOCIATED THE MOST WITH MALE-FACTOR INFERTILITY: ASSESSMENT OF THE 2010-2020 FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASE
- Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation
- Risk factors for intraoperative floppy iris syndrome: a retrospective study
- The Evolution of Emerging Nanovesicle Technologies for Enhanced Delivery of Molecules into and across the Skin
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation
- SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
- The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation
- Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
- Therapeutic Potential of Gynostemma pentaphyllum Extract for Hair Health Enhancement: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- The pattern of off-label and unlicensed drug use in adult and pediatric patients in the Kingdom of Saudi Arabia: multicenter retrospective study
- Forum
- Floppy Iris Syndrome
- Topical use of systemic drugs in dermatology: A comprehensive review
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries